Biotech firm Immunic Inc (NASDAQ:IMUX) is set to disclose its Q3 2023 financial results and provide a corporate update on November 14, 2023, before the U.S. financial markets open. A webcast is scheduled for 8:00 am ET. The company specializes in developing orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases.
The Markets by Proactive
Go to Proactive UK
Proactive’s coverage of London’s small caps continues on .com